Engineered protein complex could help immunotherapies target hard-to-treat neuroblastoma

Researchers from Children’s Hospital of Philadelphia (CHOP) have developed a method to help cancer immunotherapies reach otherwise “invisible” tumors by helping guide therapies to their appropriate targets. This could be particularly useful for…

Continue Reading

News Source: medicalxpress.com